IP Verse

Sodium Chloride Solution For Drug Reconstitution Or Dilution - EP1942868

The patent EP1942868 was granted to Wyeth on Oct 4, 2023. The application was originally filed on Oct 27, 2006 under application number EP06827036A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP1942868

WYETH
Application Number
EP06827036A
Filing Date
Oct 27, 2006
Status
Patent Maintained As Amended
Sep 1, 2023
Grant Date
Oct 4, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BRADYJan 19, 2018ZWICKERADMISSIBLE

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2001031721
INTERNATIONAL-SEARCH-REPORTUS3717708
INTERNATIONAL-SEARCH-REPORTWO2005058283
INTERNATIONAL-SEARCH-REPORTWO2005089712
OPPOSITIONWO2005058283

Non-Patent Literature (NPL) Citations (10) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
INTERNATIONAL-SEARCH-REPORT- BUSH L ET AL, "THE FORMULATION OF RECOMBINANT FACTOR IX: STABILITY, ROBUSTNESS, AND CONVENIENCE", SEMINARS IN HEMATOLOGY, PHILADELPHIA, PA, US, (199804), vol. 35, no. 2, SUPPL 2, ISSN 0037-1963, pages 18 - 21, XP001010494 [X] 33-36 * the whole document *
INTERNATIONAL-SEARCH-REPORT- VAN DEN BERG H M ET AL, "BeneFixTM induces agglutination of red cells", BLOOD, W.B.SAUNDERS COMPANY, ORLANDO, FL, US, (20001116), vol. 96, no. 11 Part 1, ISSN 0006-4971, page 641a, XP008083763 [X] 1-36 * abstract *
INTERNATIONAL-SEARCH-REPORT- VAN OSS C J, "On the mechanism of the spontaneous aggregation of human erythrocytes at reduced ionic strength and PH", BIORHEOLOGY, ELSEVIER SCIENCE LTD., OXFORD, GB, (1984), vol. 21, no. 3, ISSN 0006-355X, pages 415 - 416, XP008083758 [A] 1-36 * the whole document *
OPPOSITION- CHAI et al., "Effects on Erythrocyte Aggregation and Blood Coagulation from Iohexol Solutions with and without Sodium Chloride", Acta Radiologica, (19950000), vol. 36, pages 204 - 209, XP055609707
OPPOSITION- CONSTANTINO et al., "Excipients for use in Lyophilized Pharmaceutical Peptide, Protein, and other Bioproducts (pg 197-198)", Lyophilization of Biopharmaceuticals, (20040000), pages 139 - 228, ISBN 0-9711767-6-0, XP008159820
OPPOSITION- International Blood/Plasma News, (20010000), vol. 18, no. 9, page 127
OPPOSITION- STRANZ, "The Implications of Osmolality, Osmolarity and pH in Infusion Therapy", INS Annual Conference, (20050000), pages 1 - 5, XP055609720
OPPOSITION- VAN DEN BERG, "BeneFixTM induces agglutination of red cells:Is there a clinical relevance and can it be prevented?", Blood, (20000000), vol. 96, no. 11, part 1, page 641 a, XP008083763
OPPOSITION- BUSCHLE et al., "A compatible solution for administration with blood.", Anesthesiology, (19530000), vol. 14, pages 53 - 59, XP055609711
OPPOSITION- POWELL et al., "A New Formulation of Recombinant Human Factor IX Is Bioequivalent to BeneFIX: A Double­ Blind, Randomized, Crossover Pharmacokinetic and Open-Label Safety and Efficacy Study.", Blood, (20050000), vol. 106, no. 11, XP055609656

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents